Munafa Stock Market Course + Intraday & FNO calls 
UG NEWS why is United-guardian, Inc. price falling or rising
UG NEWS reasons for why stock price of United-guardian, Inc. is falling or rising
UG United Guardian is falling or rising technical reasons
Technical analysis forecast of United Guardian Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in United Guardian UG at this time. Stock is rising and might rise more.
It appears as if United Guardian UG gave a large move recently.
Stock of United Guardian (UG) is trading above an important moving average line, and it has been above this line for quite some time now. This is a good sign, and the stock might keep rising and move higher!
My analysis of United Guardian is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if United Guardian stays above 6.2, but if it comes below 6.2, then a intra day sell could be more profitable.
If you take a sell trade below 6.2, then use 6.2 as stoploss and 6.17 as target. However if you take a buy trade in United Guardian, then use 6.2 as stoploss and 6.3 as target.
UG United Guardian is falling or rising NEWS fundamental reasons
Delhi HC clears Zydus to sell biosimilar of BMS cancer drug Nivolumab The Delhi High Court has permitted Zydus Lifesciences to produce and market a biosimilar cancer drug. This decision comes as the patent for the original drug, Nivolumab, nears its expiration. The court prioritized patient access to affordable treatment. Zy - NEWS as on 2026-01-12 indiatimes.com
Generic drug maker Hindustan Laboratories files IPO papers with Sebi Generic drug maker Hindustan Laboratories has filed preliminary papers with capital markets regulator Sebi to raise funds through an initial public offering (IPO). - NEWS as on 2026-01-05 indiatimes.com
Ministry in talks with states to give some drug cos more time for good manufacturing practices compliance The Union Health Ministry is in talks with states about extending the deadline for pharmaceutical companies to meet new manufacturing quality rules. A six-month extension may be granted on a case-by-case basis. This move aims to prevent potential medicin - NEWS as on 2026-01-01 indiatimes.com
VNDA Obtains FDA Nod for Motion Sickness Drug, Stock Gains Vanda stock jumps after FDA approves tradipitant as Nereus for motion sickness, marking the first new therapy in over 40 years and boosting investor optimism. - NEWS as on 2025-12-31 nasdaq.com
More announcements and NEWS
UG United-guardian, Inc. current price & indicator signals
Recent prices of UG United-guardian, Inc. are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 13 Tue Jan 2026 | 6.26 | 6.21 to 6.26 | 0.64% | 0.27 times |
| 12 Mon Jan 2026 | 6.22 | 6.16 to 6.26 | -0.48% | 1.36 times |
| 09 Fri Jan 2026 | 6.25 | 6.19 to 6.35 | 0.32% | 0.96 times |
| 08 Thu Jan 2026 | 6.23 | 6.18 to 6.26 | -0.32% | 0.63 times |
| 07 Wed Jan 2026 | 6.25 | 6.14 to 6.25 | 0.81% | 1.04 times |
| 06 Tue Jan 2026 | 6.20 | 6.14 to 6.23 | 0.16% | 0.55 times |
| 05 Mon Jan 2026 | 6.19 | 6.14 to 6.19 | 0.98% | 0.44 times |
| 02 Fri Jan 2026 | 6.13 | 6.11 to 6.21 | -0.49% | 0.37 times |
| 31 Wed Dec 2025 | 6.16 | 6.10 to 6.16 | 0.16% | 1.5 times |
| 30 Tue Dec 2025 | 6.15 | 6.08 to 6.18 | 0.82% | 1.93 times |
| 29 Mon Dec 2025 | 6.10 | 6.10 to 6.20 | -1.61% | 1.22 times |
| 26 Fri Dec 2025 | 6.20 | 6.10 to 6.25 | 1.31% | 3.07 times |
Videos related to: UG NEWS why is United-guardian, Inc. price falling or rising
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
